What is the window for Human Immunodeficiency Virus (HIV) detection after potential exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIV Detection Window Period

The window period for HIV detection depends on the test type: diagnostic nucleic acid tests (NAT) can detect HIV approximately 10-14 days after exposure, fourth-generation antigen/antibody (Ag/Ab) tests detect HIV at 18-24 days, and third-generation antibody-only tests require 22-25 days. 1, 2, 3

Test-Specific Window Periods

Nucleic Acid Testing (NAT/RNA Tests)

  • Diagnostic NAT can detect acute HIV infection approximately 1 week before laboratory-based Ag/Ab tests, making it the most sensitive early detection method 1
  • The eclipse period (exposure to first RNA detection) is approximately 10 days 2, 3
  • NAT is particularly important when recent antiretroviral exposure may suppress antibody response 1

Fourth-Generation Ag/Ab Tests

  • Median window period is 18 days (range 16-24 days) after exposure 3
  • These tests detect both p24 antigen and HIV antibodies, reducing the window to 11-14 days in optimal conditions 4
  • The 99th percentile window period is approximately 44 days, meaning virtually all infections are detectable by this time 2

Third-Generation Antibody Tests

  • Median window period is 22 days (range 19-25 days) 3
  • The 99th percentile window period extends to 80 days post-exposure 3
  • These older tests are less sensitive for acute infection 4

Clinical Testing Algorithm After Exposure

Baseline Testing (Immediate)

  • Use rapid point-of-care or laboratory-based Ag/Ab test at initial encounter 1
  • Add laboratory-based Ag/Ab test if rapid test used initially to increase sensitivity 1
  • Consider adding HIV NAT for baseline testing if the person recently took oral antiretrovirals or received cabotegravir injection within the past year 1

Follow-Up Testing Timeline (Without PEP)

For individuals NOT on post-exposure prophylaxis:

  • Test at 6 weeks, 3 months, and 6 months post-exposure using traditional antibody tests 1, 5
  • Test immediately if acute retroviral syndrome symptoms develop, regardless of timeline 5

Follow-Up Testing Timeline (With PEP)

For individuals receiving post-exposure prophylaxis, the timeline differs because antiretrovirals can suppress viral load and delay seroconversion:

  • First follow-up: 4-6 weeks after PEP initiation (within 2 weeks of completing 28-day course) 1

    • Use both laboratory-based Ag/Ab test AND diagnostic NAT 1
    • A negative test does NOT rule out HIV because PEP medications may suppress detection 1
  • Final follow-up: 12 weeks after PEP initiation (8 weeks after PEP completion) 1

    • Use both laboratory-based Ag/Ab test AND diagnostic NAT 1
    • This timing accounts for antiretroviral washout and test window periods 1
    • This is the definitive test to rule out HIV infection from the exposure 1

Important Clinical Caveats

Antiretroviral Impact on Testing

  • ARVs taken as PEP or PrEP can suppress HIV viral load, delay seroconversion, and decrease ability to detect HIV infection 1
  • This is why both Ag/Ab testing AND NAT are required for follow-up in PEP recipients 1

Test Selection Pitfalls

  • Oral fluid-based rapid HIV tests are NOT recommended in the PEP context because they are less sensitive for acute or recent infection than blood tests 1
  • If recommended tests unavailable, use the most sensitive accessible HIV test 1

Extended Follow-Up Scenarios

  • 12-month extended follow-up is recommended for healthcare workers who become infected with HCV following exposure to a source coinfected with HIV and HCV 5

Probability of False-Negative Results

  • For fourth-generation tests: probability of false-negative is 0.01 (1%) at 42 days post-exposure 3
  • For third-generation tests: probability of false-negative is 0.01 (1%) at 80 days post-exposure 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Time Until Emergence of HIV Test Reactivity Following Infection With HIV-1: Implications for Interpreting Test Results and Retesting After Exposure.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017

Research

Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution.

Clinical and vaccine immunology : CVI, 2016

Guideline

HIV Testing Follow-Up After Occupational Exposure: Current Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.